Related references
Note: Only part of the references are listed.CircRNA 001372 Reduces Inflammation in Propofol-Induced Neuroinflammation and Neural Apoptosis through PIK3CA/Akt/NF-κB by miRNA-148b-3p
Mingyu Wang et al.
JOURNAL OF INVESTIGATIVE SURGERY (2021)
Anti-tumor Activity of Propofol: A Focus on MicroRNAs
Milad Ashrafizadeh et al.
CURRENT CANCER DRUG TARGETS (2020)
miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating HOXA9
Kun Qin et al.
JOURNAL OF GENE MEDICINE (2020)
Circular RNA MAPK4 (circ-MAPK4) inhibits cell apoptosis via MAPK signaling pathway by sponging miR-125a-3p in gliomas
Jiehua He et al.
MOLECULAR CANCER (2020)
Functions and clinical significance of circular RNAs in glioma
Jikui Sun et al.
MOLECULAR CANCER (2020)
Propofol Inhibits the Migration and Invasion of Glioma Cells by Blocking the PI3K/AKT Pathway Through miR-206/ROCK1 Axis
Dongmei Wang et al.
ONCOTARGETS AND THERAPY (2020)
Propofol Inhibits Cell Proliferation, Migration, and Invasion via mir-410-3p/Transforming Growth Factor-β Receptor Type 2 (TGFBR2) Axis in Glioma
Fengli Li et al.
MEDICAL SCIENCE MONITOR (2020)
Recent updates on true potential of an anesthetic agent as a regulator of cell signaling pathways and non-coding RNAs in different cancers: Focusing on the brighter side of propofol
Ammad Ahmad Farooqi et al.
GENE (2020)
Advances in circular RNAs and their role in glioma (Review)
Yuhao Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Effects of propofol on the development of cancer in humans
Yichi Xu et al.
CELL PROLIFERATION (2020)
Challenges to curing primary brain tumours
Kenneth Aldape et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Low microRNA-622 expression predicts poor prognosis and is associated with ZEB2 in glioma
Qian Song et al.
ONCOTARGETS AND THERAPY (2019)
MicroRNA-622 suppresses the proliferation of glioma cells by targeting YAP1
Jin Xu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Surgical oncology for gliomas: the state of the art
Nader Sanai et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Propofol
Marko M. Sahinovic et al.
CLINICAL PHARMACOKINETICS (2018)
Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment
Ching-Ann Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
WHO 2016 Classification of gliomas
P. Wesseling et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Propofol inhibits Wnt signaling and exerts anticancer activity in glioma cells
Wei Xu et al.
ONCOLOGY LETTERS (2018)
The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma
Ana Xavier-Magalhães et al.
Oncotarget (2018)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
Propofol inhibits invasion and proliferation of C6 glioma cells by regulating the Ca2+ permeable AMPA receptor-system xc- pathway
Xin-yue Wang et al.
TOXICOLOGY IN VITRO (2017)
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications
Silvia Anahi Valdes-Rives et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Perioperative Anesthesia Care and Tumor Progression
Mir W. Sekandarzad et al.
ANESTHESIA AND ANALGESIA (2017)
Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma
Xinzhi Wang et al.
TUMOR BIOLOGY (2016)
Role of MicroRNAs in Malignant Glioma
Bao-Cheng Wang et al.
CHINESE MEDICAL JOURNAL (2015)
Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression
Jinquan Xu et al.
MOLECULAR MEDICINE REPORTS (2015)
miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells
Rui Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
HOX genes and their role in the development of human cancers
Seema Bhatlekar et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Quantitative methylation analysis of HOXA3, 7, 9, and 10 genes in glioma: association with tumor WHO grade and clinical outcome
Angela Di Vinci et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Share Paper
